Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Brain Neoplasms 5Glioma 4Breast Neoplasms 4Prostatic Neoplasms 2Neoplasms 2Lymphoma, Large B-Cell, Diffuse 2Vision Disorders 1Uterine Cervical Neoplasms 1Turcot syndrome 1Tongue Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Salivary Gland Neoplasms 1Rectal Neoplasms 1Pituitary Neoplasms 1Peripheral Nervous System Diseases 1Oligodendroglioma 1Neurotoxicity Syndromes 1Neuritis 1Neoplasm Metastasis 1Medulloblastoma 1Mediastinal Neoplasms 1Lymphedema 1Lung Neoplasms 1Head and Neck Neoplasms 1Gliosarcoma 1Glioblastoma 1Familial ependymoma 1Esthesioneuroblastoma, Olfactory 1Ependymoma 1Diffuse Intrinsic Pontine Glioma 1

Interventions

Temozolomide 131Radiotherapy 87Bevacizumab 43Radiation 31Carmustine 29Magnetic Resonance Spectroscopy 22Irinotecan 22Erlotinib Hydrochloride 22Chemotherapy, Adjuvant 20Surgical Procedures, Operative 15O(6)-benzylguanine 15Carboplatin 14Radiotherapy, Intensity-Modulated 13Radiotherapy, Conformal 13sargramostim 12Sirolimus 9Imatinib Mesylate 9Filgrastim 9Drug Therapy 9temsirolimus 8Thalidomide 8Sorafenib 8Radiosurgery 8pembrolizumab 7motexafin gadolinium 7aldesleukin 7Vorinostat 7Procarbazine 7Gene Expression Profiling 7Gefitinib 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gliosarcoma × Diffusion Tensor Imaging × Clear all
NCT00662506 2023-06-06

Cediranib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma

National Cancer Institute (NCI)

Phase 1/2 Completed
46 enrolled
CNSSarcoma

Glioblastoma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡